JAC Advance Access originally published online on March 15, 2008
Journal of Antimicrobial Chemotherapy 2008 61(6):1376-1383; doi:10.1093/jac/dkn104
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original research |
Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes
1 Division of Infectious Diseases, Washington University School of Medicine, St Louis, MO, USA 2 Center for Healthcare Quality and Effectiveness, BJC Healthcare,St Louis, MO, USA
Received 11 December 2007; returned 28 December 2007; revised 13 February 2008; accepted 18 February 2008
* Corresponding author. Tel: +1-314-454-8044; Fax: +1-314-454-8294; E-mail: jmarscha{at}im.wustl.edu
Background: A considerable number of Gram-negative bacteraemias occur outside intensive care units (ICUs). Inadequate antibiotic therapy in ICUs has been associated with adverse outcomes; however, there are no prospective studies in non-ICU patients.
Methods: A 6 month (1 August 2006–31 January 2007), prospective cohort study of non-ICU patients with Gram-negative bacteraemia in a tertiary-care hospital was performed. Inadequate empirical antibiotic therapy was defined as no antibiotic or starting a non-susceptible antibiotic within 24 h after the initial positive blood culture.
Results: Two hundred and fifty non-ICU patients had Gram-negative bacteraemia. The mean age was 56.4 (±16.1) years. The predominant bacteria in monomicrobial infections were Escherichia coli (24%), Klebsiella pneumoniae (18%) and Pseudomonas aeruginosa (8%). Sixty-one (24%) patients had polymicrobial bacteraemia. Seventy patients (28%) required ICU transfer and 35 (14%) died. Seventy-nine (31.6%) received inadequate empirical antibiotic therapy. These patients were more likely to have a hospital-acquired infection [odds ratio (OR) = 1.99, 95% confidence interval (CI) = 1.11–3.56, P = 0.02] and less likely to have E. coli monomicrobial bacteraemia [OR 0.40 (95% CI 0.19–0.86), P = 0.02]. There were no differences in occurrence of sepsis [72 (91.1%) patients with inadequate versus 159 (93.0%) with adequate therapy; P = 0.6], ICU transfer [20 (25.3%) versus 50 (29.2%); P = 0.5], post-bacteraemia length of stay (median = 6.8 versus 6.1 days; P = 0.09) or death [11 (13.9%) versus 24 (14.0%); P = 1.0].
Conclusions: Nearly one-third of the non-ICU patients with Gram-negative bacteraemia received inadequate empirical antibiotic therapy. There was no difference in adverse outcomes between patients receiving inadequate or adequate therapy in this study.
Keywords: bloodstream infection , Gram-negative bacteria , antibacterial agents , non-intensive care , mortality